Directory
>
Harlan Waksal Md
Harlan Waksal Md
Executive Chairman | Lyra Therapeutics
New York, New York, United States
Harlan Waksal Md
Summary
Dr. Harlan Waksal is a seasoned executive with extensive experience in the biopharmaceutical and consulting industries. As the President of Waksal Consulting LLC, he leverages his expertise to guide biotechnology companies in strategic business and clinical development. His previous roles include Executive Chairman at Lyra Therapeutics and President & CEO of Kadmon Holdings, where he played a pivotal role in advancing innovative therapies. Dr. Waksal co-founded ImClone Systems, a company known for its groundbreaking cancer treatments, which was acquired by Eli Lilly for $6.5 billion. He holds a Doctor of Medicine degree from Tufts University School of Medicine and a Bachelor's degree from Oberlin College. His leadership extends to various boards, reflecting his commitment to the advancement of science and education. Dr. Waksal's career is marked by a blend of entrepreneurial spirit and dedication to improving healthcare outcomes.
Harlan Waksal Md
Work Experience
Executive Chairman at
Lyra Therapeutics
February 2022 - Present
Member of the Advisory Board at
Roadmap Capital
January 2011 - Present
President at
Waksal Consulting LLC
July 2003 - Present
President & CEO at
Kadmon, a Sanofi Company
August 2014 - November 2021
Member of the Board of Directors at
Kadmon, a Sanofi Company
December 2013 - November 2021
Chairman of the Board at
Senesco Technologies, Inc.
January 2009 - January 2016
Member of the Board of Directors at
Neptune Technologies And Bioresources
January 2012 - January 2016
Member of the Board of Directors at
Senesco Technologies, Inc.
January 2008 - January 2016
Member of the Board of Trustees at
Oberlin College
January 2006 - January 2016
Member of the Board of Directors at
Acasti Pharma Inc.
January 2012 - January 2016
EVP, Business & Scientific Affairs at
Acasti Pharma Inc.
January 2011 - January 2014
Observer of the Board of Directors at
Neurobiopharm
January 2012 - January 2014
President and Owner at
Waksal Consulting LLC
January 2003 - January 2014
Member of the Board of Trustees at
Montclair Art Museum
January 2004 - January 2010
Chairman at
American Committee For The Weizmann Institute of Science
January 2005 - January 2010
Member of the Technology Advisory Board at
New Jersey Edison Innovation Fund
January 2006 - January 2009
Co-Founder at
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
January 1987 - January 2008
Member of the Board of Directors at
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
January 1987 - January 2005
EVP, Chief Operating Officer at
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
January 1994 - January 2002
President at
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
January 1987 - January 1994
Harlan Waksal Md
Education
Tufts University School of Medicine, Doctor Of Medicine (Md)
January 1979
Oberlin College, Bachelor's Degree
January 1975
Frequently Asked Questions about Harlan Waksal Md
What is Harlan Waksal Md email address?
Harlan Waksal Md's primary email address is *******@lyratx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Harlan Waksal Md work for?
Harlan Waksal Md is a Executive Chairman at Lyra Therapeutics, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Harlan Waksal Md graduated from?
Harlan Waksal Md holds a degree in from Tufts University School of Medicine.
How can I directly contact Harlan Waksal Md?
To contact Harlan Waksal Md directly, you can use the email address *******@lyratx.com. Complete contact information is available upon registration with Muraena.
Who is Harlan Waksal Md?
Dr. Harlan Waksal is a seasoned executive with extensive experience in the biopharmaceutical and consulting industries. As the President of Waksal Consulting LLC, he leverages his expertise to guide biotechnology companies in strategic business and clinical development. His previous roles include Executive Chairman at Lyra Therapeutics and President & CEO of Kadmon Holdings, where he played a pivotal role in advancing innovative therapies. Dr. Waksal co-founded ImClone Systems, a company known for its groundbreaking cancer treatments, which was acquired by Eli Lilly for $6.5 billion. He holds a Doctor of Medicine degree from Tufts University School of Medicine and a Bachelor's degree from Oberlin College. His leadership extends to various boards, reflecting his commitment to the advancement of science and education. Dr. Waksal's career is marked by a blend of entrepreneurial spirit and dedication to improving healthcare outcomes.
Harlan`s contact details
*******@lyratx.com
*************@kadmon.com
Colleagues
Senior Vice President Quality & Technical Operations
Board Member
Associate Vice President
Senior Vice President Operations
Senior Vice President, Investor Relations and Communications
Chief Medical Officer
Associate Vice President, Clinical Operations
Associate Vice President Finance
Senior Vice President, Clinical Affairs
Senior Vice President, Regulatory Affairs